METASTATIC PDAC
Clinical trials for METASTATIC PDAC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PDAC trials appear
Sign up with your email to follow new studies for METASTATIC PDAC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double antibody attack targets hard-to-treat pancreatic cancer
Disease control OngoingThis study tests whether adding a new antibody (HLX22) to standard treatment (trastuzumab plus chemo) can shrink tumors better in people with advanced HER2-positive pancreatic cancer. About 45 adults who have not had prior treatment for metastatic disease will receive the combina…
Matched conditions: METASTATIC PDAC
Phase: PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Desperate patients get early access to experimental cachexia drug
Symptom relief NO_LONGER_AVAILABLEThis program gives seriously ill adults with advanced pancreatic cancer and severe weight loss (cachexia) early access to the experimental drug mifomelatide. It is for patients who have no other treatment options for their weight loss and cannot join current clinical trials. Doct…
Matched conditions: METASTATIC PDAC
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated May 26, 2026 11:12 UTC